FOF/ED  New York Ventures capital

     Office Locations:

633 3rd Avenue, 33rd Floor
New York, NY 10017



  • Early
  • Seed



  • Information Technology
  • Life Sciences & Healthcare



    Administered by Empire State Development, New York Ventures meets the critical capital needs of New York State's innovation economy by providing funding to high-growth startups as they move from concept to commercialization, through early growth and expansion. New York Ventures administers the State's innovation investment funds, providing equity investment capital to early-stage technology-based businesses through direct investments and fund-of-funds. New York Ventures actively looks to fill funding gaps in key, but underserved, industries and regions. The firm supports companies emerging from NY State universities, research labs, incubators and accelerators- but will consider companies willing to relocate to New York. New York Ventures administers more than $90 million in capital allocated toward direct equity investments into promising startups. The direct investment program focuses on Series A investments, but will selectively consider seed rounds. The New York Ventures fund-of-funds investment programs are typically targeted at specific investment stages, industry sectors or founder groups, and are administered by third-party investment managers selected on a competitive basis.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Brian Keil Managing Director
    Sharon Weinberg Managing Director


    Recent Funding Events (trailing 12 months):










      Seed 2







      Quentis Therapeutics



      Series A


    Portfolio companies include:

        web link

        web link

      Quentis Therapeutics
        web link


    Recent News: